BIOC 230
Activating Mutations in the Epidermal Growth Factor Receptor that Underlie the Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib
BIOC 230 • Stanford University
You Might Also Like
BIOC 230Stanford University
Allele-Specific Treatments for Cystic Fibrosis
BIOC 230Stanford University
Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus
BIOC 230Stanford University
HIV Entry and Its Inhibition
BIOC 230Stanford University
Physiological Response to Long-Term Peripheral and Central Leptin Infusion in Lean and Obese Mice - 6 Pages
BIOC 230Stanford University
Effects of NOS3 Glu298Asp Polymorphism on Hemodynamic Parameters
BIOC 230Stanford University